Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Hormone replacement therapy after surgery for epithelial ovarian cancer

Esta versión no es la más reciente

ver la versión actual 28 enero 2020

Información

DOI:
https://doi.org/10.1002/14651858.CD012559Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 24 febrero 2017see what's new
Tipo:
  1. Intervention
Etapa:
  1. Protocol
Grupo Editorial Cochrane:

  1. Grupo Cochrane de Cáncer ginecológico, neurooncología y otros cánceres

Copyright:
  1. Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Nungrutai Saeaib

    Correspondencia a: Department of Obstetrics and Gynecology, Faculty of Medicine, Prince of Songkla University, Hat Yai, Thailand

    [email protected]

  • Krantarat Peeyananjarassri

    Department of Obstetrics and Gynecology, Faculty of Medicine, Prince of Songkla University, Hat Yai, Thailand

  • Tippawan Liabsuetrakul

    Epidemiology Unit, Faculty of Medicine, Prince of Songkla University, Hat Yai, Thailand

  • Rakchai Buhachat

    Department of Obstetrics and Gynecology, Faculty of Medicine, Prince of Songkla University, Hat Yai, Thailand

  • Eva Myriokefalitaki

    Gynaecological Oncology, The Christie NHS Foundation Trust, Manchester, UK

Contributions of authors

Protocol development: NS, EM, TL
Selection of studies: NS, RB
Eligibility of studies: NS, RB, third person: TL
Data extraction: NS, KP, third person: RB
Data entry into RevMan: NS, spot‐check: KP
Assessment of risk of bias: NS, RB, third person: EM
Draft the final review: NS, RB, KP, TL, EM
Update the review: NS, RB, KP, TL, EM

Declarations of interest

Nungrutai Saeaib: None known
Krantarat Peeyananjarassri: None known
Tippawan Liabsuetrakul: None known
Rakchai Buhachat: None known
Eva Myriokefalitaki: None known

Acknowledgements

We thank Jo Morrison for clinical and editorial advice, Jane Hayes and Jo Platt for designing the search strategy and Gail Quinn, Clare Jess and Tracey Harrison for their contribution to the editorial process.

This project was supported by the National Institute for Health Research (NIHR), via Cochrane infrastructure funding to the Cochrane Gynaecological, Neuro‐oncology and Orphan Cancers Group. The views and opinions expressed herein are those of the review authors and do not necessarily reflect those of the Systematic Reviews Programme, NIHR, National Health Service, or the Department of Health.

We thank the referees for many helpful suggestions and comments; these referees included Fani Kokka, Elly Brockbank, Ruth Payne and Nicolette Biglia.

Version history

Published

Title

Stage

Authors

Version

2020 Jan 28

Hormone replacement therapy after surgery for epithelial ovarian cancer

Review

Nungrutai Saeaib, Krantarat Peeyananjarassri, Tippawan Liabsuetrakul, Rakchai Buhachat, Eva Myriokefalitaki

https://doi.org/10.1002/14651858.CD012559.pub2

2017 Feb 24

Hormone replacement therapy after surgery for epithelial ovarian cancer

Protocol

Nungrutai Saeaib, Krantarat Peeyananjarassri, Tippawan Liabsuetrakul, Rakchai Buhachat, Eva Myriokefalitaki

https://doi.org/10.1002/14651858.CD012559

Keywords

MeSH

Medical Subject Headings (MeSH) Keywords

Medical Subject Headings Check Words

Female; Humans;

PICO

Population
Intervention
Comparison
Outcome

El uso y la enseñanza del modelo PICO están muy extendidos en el ámbito de la atención sanitaria basada en la evidencia para formular preguntas y estrategias de búsqueda y para caracterizar estudios o metanálisis clínicos. PICO son las siglas en inglés de cuatro posibles componentes de una pregunta de investigación: paciente, población o problema; intervención; comparación; desenlace (outcome).

Para saber más sobre el uso del modelo PICO, puede consultar el Manual Cochrane.